Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

darifenacin

darifenacin
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Enablex TABLET, EXTENDED RELEASE, ORAL 7.5 mg, 15 mg    
VIEW MORE Genitourinary Smooth Muscle Relaxants
CLASS
861200
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

darifenacin (Enablex)

  • 7.5 mg extended release tablet oral Daily
  • 15 mg extended release tablet oral Daily

oxybutynin (Ditropan XL)

  • 5 mg/24 hours extended release tablet oral Daily
  • 10 mg/24 hours extended release oral Daily

Reviewed: April 27, 2005

Last updated: Dec. 20, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved